PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Nateglinide and Clonidine Interaction

Drug interaction information between Nateglinide and Clonidine.

Nateglinide and Clonidine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Nateglinide and Clonidine. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.

Drug A

Nateglinide

Meglitinide

Drug B

Clonidine

Central Alpha-2 Agonist

How They Interact

Clonidine can hide the normal warning signs of low blood sugar, such as a racing heart or shakiness. This makes it difficult to tell if your blood sugar has dropped to a dangerous level.

What To Do

You should check your blood sugar levels more frequently when taking these two medications together.

FDA Label Information

Drugs That May Blunt Signs and Symptoms of Hypoglycemia Drugs: beta-blockers, clonidine, guanethidine, and reserpine Intervention: Increased frequency of glucose monitoring may be required when nateglinide is coadministered with these drugs.

Clonidine Also Interacts With

View all Clonidine interactions →

Frequently Asked Questions

Can I take Nateglinide and Clonidine together?

This is a minor interaction. You should check your blood sugar levels more frequently when taking these two medications together.

How serious is the interaction between Nateglinide and Clonidine?

This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.

Why do Nateglinide and Clonidine interact?

Clonidine can hide the normal warning signs of low blood sugar, such as a racing heart or shakiness. This makes it difficult to tell if your blood sugar has dropped to a dangerous level.

Understanding the Nateglinide and Clonidine Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Nateglinide belongs to the Meglitinide class and Clonidine belongs to the Central Alpha-2 Agonist class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Clonidine can hide the normal warning signs of low blood sugar, such as a racing heart or shakiness. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Nateglinide has 9 total documented interactions on file in this dataset, and Clonidine has 29. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: You should check your blood sugar levels more frequently when taking these two medications together. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Nateglinide or Clonidine based on a web page, speak with your prescriber or pharmacist before making any change.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.